There are 749 resources available
PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in NSCLC
Presenter: Jiaqing Liu
Session: Mini Oral session - Immunotherapy of cancer
Resources:
Slides
Webcast
Data-driven miRNA classifier as response predictor for immune checkpoint inhibitor treatment in advanced-stage cancer patients
Presenter: Chia-Hsun Hsieh
Session: Mini Oral session - Immunotherapy of cancer
Resources:
Slides
Webcast
LBA14 - Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy
Presenter: Afaf Abed
Session: Mini Oral session - Immunotherapy of cancer
Resources:
Abstract
Slides
Webcast
318O - Both low and high blood tumour mutational burden are favourable predictors with atezolizumab
Presenter: Wei Nie
Session: Mini Oral session - Immunotherapy of cancer
Resources:
Abstract
225O - Impact of radiological disease progression on the health status of patients (pts) with BRCA-mutated advanced ovarian cancer (OC) treated with maintenance olaparib (OL) or placebo (PL) after first-line platinum chemotherapy
Presenter: Michael Friedlander
Session: Proffered paper session - Gynaecological cancers
Resources:
Abstract
Liquid biomarkers for NSCLC
Presenter: Yasushi Goto
Session: Perspective of liquid biomarkers for cancer care
Resources:
Slides
Webcast
Liquid biomarkers for advanced GI cancer
Presenter: Kohei Shitara
Session: Perspective of liquid biomarkers for cancer care
Resources:
Slides
Webcast
Liquid biomarkers for immunotherapy
Presenter: François Clément Bidard
Session: Perspective of liquid biomarkers for cancer care
Resources:
Slides
Webcast
Colorectal cancer
Presenter: Alberto Sobrero
Session: Adjuvant treatment in gastrointestinal cancer
Resources:
Slides
Webcast
Gastric cancer
Presenter: Yasuhiro Kodera
Session: Adjuvant treatment in gastrointestinal cancer
Resources:
Slides
Webcast